| Q37238430 | A Th1 cytokine–enriched microenvironment enhances tumor killing by activated T cells armed with bispecific antibodies and inhibits the development of myeloid-derived suppressor cells |
| Q48919218 | A generic RNA pulsed DC based approach for developing therapeutic intervention against nasopharyngeal carcinoma |
| Q24814644 | A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma |
| Q34768502 | A population of HLA-DR+ immature cells accumulates in the blood dendritic cell compartment of patients with different types of cancer |
| Q38527867 | A top-down view of the tumor microenvironment: structure, cells and signaling |
| Q39113879 | A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells. |
| Q30316394 | Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis |
| Q33746583 | Activation of tolerogenic dendritic cells in the tumor draining lymph nodes by CD8+ T cells engineered to express CD40 ligand |
| Q92072042 | Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment |
| Q36671247 | Altered maturation of peripheral blood dendritic cells in patients with breast cancer. |
| Q37344594 | Antigen presenting cells treated in vitro by macrophage colony-stimulating factor and autoantigen protect mice from autoimmunity. |
| Q35653176 | Autocrine CSF-1 and CSF-1 Receptor Coexpression Promotes Renal Cell Carcinoma Growth |
| Q58695193 | Bone marrow mesenchymal stem cells tune the differentiation of myeloid-derived suppressor cells in bleomycin-induced lung injury |
| Q38247941 | Brain APCs including microglia are only differential and positional polymorphs. |
| Q33553562 | CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization |
| Q89821709 | CD163+ tumor-associated macrophage accumulation in breast cancer patients reflects both local differentiation signals and systemic skewing of monocytes |
| Q37461490 | CD99-Dependent Expansion of Myeloid-Derived Suppressor Cells and Attenuation of Graft-Versus-Host Disease |
| Q37769017 | Cancer-associated myeloproliferation: old association, new therapeutic target |
| Q91825034 | Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs |
| Q91923409 | Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity |
| Q47097684 | Change in the immune function of porcine iliac artery endothelial cells infected with porcine circovirus type 2 and its inhibition on monocyte derived dendritic cells maturation |
| Q34002668 | Chemokines and dendritic cell traffic. |
| Q36016640 | Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF |
| Q37692855 | Collagen as a double-edged sword in tumor progression |
| Q34093784 | Complex role for the immune system in initiation and progression of pancreatic cancer. |
| Q38124437 | Deciphering and reversing tumor immune suppression. |
| Q36464882 | Defective differentiation of myeloid and plasmacytoid dendritic cells in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial growth factor receptor. |
| Q34521014 | Dendritic Cell Activation by Glucan Isolated fromUmbilicaria Esculenta |
| Q26774345 | Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy |
| Q38284706 | Dendritic cell defects in the colorectal cancer |
| Q35063118 | Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas |
| Q35584599 | Dendritic cells and malignant plasma cells: an alliance in multiple myeloma tumor progression? |
| Q36569018 | Dendritic cells and tumor microenvironment: a dangerous liaison |
| Q24792153 | Dendritic cells: In the forefront of immunopathogenesis and vaccine development - A review |
| Q33890355 | Dendritic cells: immunological sentinels with a central role in health and disease. |
| Q36597391 | Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer |
| Q37565164 | Elevated serum levels of vascular endothelial growth factor is effective as a marker for malnutrition and inflammation in patients with ovarian cancer |
| Q34919077 | Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer |
| Q39249589 | Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don't Forget the Fuel |
| Q34419349 | Ex vivo development, expansion and in vivoanalysis of a novel lineage of dendritic cells from hematopoietic stem cells |
| Q34983782 | Exogenous Control of the Expression of Group I CD1 Molecules Competent for Presentation of Microbial Nonpeptide Antigens to Human T Lymphocytes |
| Q64118516 | Exposure to Low-Dose Radiation Enhanced the Antitumor Effect of a Dendritic Cell Vaccine |
| Q50091802 | Frequency and proliferative response of circulating invariant natural killer T cells in pediatric patients with malignant solid tumors |
| Q78576588 | Gangliosides inhibit the development from monocytes to dendritic cells |
| Q36212274 | Ganoderma lucidum beta 1,3/1,6 glucan as an immunomodulator in inflammation induced by a high-cholesterol diet |
| Q64891812 | Gastric carcinogenesis. |
| Q24792808 | Gene Therapy Applications to Cancer Treatment |
| Q38531845 | Generation of functional monocyte-derived fast dendritic cells suitable for clinical application in the absence of interleukin-6 |
| Q43110927 | Generation of myeloid-derived suppressor cells using prostaglandin E2 |
| Q37587362 | Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies. |
| Q52682751 | Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy |
| Q34768526 | HLA-DR+ immature cells exhibit reduced antigen-presenting cell function but respond to CD40 stimulation |
| Q37856017 | Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion |
| Q40334080 | Histone deacetylase inhibition facilitates GM-CSF-mediated expansion of myeloid-derived suppressor cells in vitro and in vivo |
| Q33652079 | Homeobox transcription factor VentX regulates differentiation and maturation of human dendritic cells |
| Q42279281 | Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells |
| Q36559879 | Human monocytes undergo functional re-programming during differentiation to dendritic cell mediated by human extravillous trophoblasts |
| Q92797185 | Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease |
| Q38608340 | Immunological hallmarks of stromal cells in the tumour microenvironment |
| Q36987882 | Impact of postoperative complications on long-term survival after radical resection for gastric cancer |
| Q92827478 | Impact of postoperative major complications on long-term survival after radical resection of gastric cancer |
| Q36375533 | In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. |
| Q37119585 | Incidence of Perioperative Complications Following Resection of Adrenocortical Carcinoma and Its Association with Long-Term Survival. |
| Q40030490 | Increased pressure stimulates aberrant dendritic cell maturation |
| Q36441408 | Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. |
| Q37250475 | Inflammation and stem cells in gastrointestinal carcinogenesis. |
| Q35024882 | Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms |
| Q24641894 | Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein |
| Q34926323 | Inhibition of the differentiation of monocyte-derived dendritic cells by human gingival fibroblasts |
| Q38061429 | Instruction of myeloid cells by the tumor microenvironment: Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations. |
| Q79353329 | Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk |
| Q36057482 | Lymphopenia combined with low TCR diversity (divpenia) predicts poor overall survival in metastatic breast cancer patients. |
| Q36368813 | Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. |
| Q53493928 | Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells |
| Q99583885 | Metabolic reprograming of tumor-associated macrophages |
| Q24792515 | Metastatic Breast Tumour Regression Following Treatment by a Gene-Modified Vaccinia Virus Expressing MUC1 and IL-2 |
| Q34407541 | Modeling putative therapeutic implications of exosome exchange between tumor and immune cells |
| Q38994510 | Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells |
| Q36376366 | Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development |
| Q35807016 | Mushroom β-Glucan May Immunomodulate the Tumor-Associated Macrophages in the Lewis Lung Carcinoma |
| Q55056515 | Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma. |
| Q27000087 | Myeloid-Derived Suppressor Cells and anti-tumor T cells: a complex relationship |
| Q28131637 | Myeloid-derived suppressor cells as regulators of the immune system |
| Q90751684 | NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis |
| Q36611476 | Numerical and functional defects of blood dendritic cells in early- and late-stage breast cancer |
| Q52662023 | Obesity and Cancer: Existing and New Hypotheses for a Causal Connection |
| Q38968944 | On the origin of myeloid-derived suppressor cells. |
| Q64071715 | Oxymatrine‑mediated maturation of dendritic cells leads to activation of FOXP3+/CD4+ Treg cells and reversal of cisplatin‑resistance in lung cancer cells |
| Q37193568 | PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment |
| Q28392626 | Pathological mobilization and activities of dendritic cells in tumor-bearing hosts: challenges and opportunities for immunotherapy of cancer |
| Q34502899 | Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment |
| Q99240043 | Perineural Invasion and Postoperative Complications are Independent Predictors of Early Recurrence and Survival Following Curative Resection of Gastric Cancer |
| Q35175502 | Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction |
| Q35553327 | Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. |
| Q34602296 | Post-operative morbidity results in decreased long-term survival after resection for hilar cholangiocarcinoma |
| Q86876276 | Postoperative Complications Influence Prognosis and Recurrence Patterns in Periampullary Cancer |
| Q89543537 | Postoperative Infectious Complications Impact Long-Term Survival in Patients Who Underwent Hepatectomies for Colorectal Liver Metastases: a Propensity Score Matching Analysis |
| Q39939540 | Prevention of both direct and cross-priming of antitumor CD8+ T-cell responses following overproduction of prostaglandin E2 by tumor cells in vivo |
| Q51050849 | Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation |
| Q33578067 | Production of TGF-beta1 as a Mechanism for Defective Antigen-presenting Cell Function of Macrophages Generated in vitro with M-CSF. |
| Q36649036 | Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients |
| Q89272533 | Prognostic value of the combination of pre- and postoperative C-reactive protein in colorectal cancer patients |
| Q39012425 | Pten null prostate epithelium promotes localized myeloid-derived suppressor cell expansion and immune suppression during tumor initiation and progression |
| Q35478848 | Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression |
| Q28076327 | Reducing the burden of obesity-associated cancers with anti-inflammatory long-chain omega-3 polyunsaturated fatty acids |
| Q38807680 | Reduction of liver metastases outgrowth by tumour antigen-pulsed dendritic cell vaccination |
| Q34314210 | Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway |
| Q40863009 | Rescue management of early complications after liver transplantation-key for the long-term success |
| Q36866959 | Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib |
| Q36384598 | Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function |
| Q33796554 | Roles for inflammation and regulatory T cells in colon cancer |
| Q39054602 | Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations |
| Q26752817 | Sensitivity of Dendritic Cells to Microenvironment Signals |
| Q47119947 | Serum Soluble Interleukin-2 Receptor is Increased in Malnourished and Immunosuppressed Patients With Gastric and Colorectal Cancer: Possible Influence of Myeloid-Derived Suppressor Cells |
| Q42120849 | Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system |
| Q39337946 | Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells |
| Q64236633 | Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation |
| Q37040443 | Suppression of natural killer-cell and dendritic-cell apoptotic tumoricidal activity in patients with head and neck cancer |
| Q38103582 | T-Cell Tolerance in Cancer |
| Q40088629 | The absence of invariant chain in MHC II cancer vaccines enhances the activation of tumor-reactive type 1 CD4+ T lymphocytes. |
| Q42017071 | The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues |
| Q30317628 | The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape |
| Q38563907 | The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity |
| Q37397746 | The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients. |
| Q35016807 | The macrophage growth factor CSF-1 in mammary gland development and tumor progression |
| Q89498378 | The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation |
| Q89509415 | Toll-like Receptors from the Perspective of Cancer Treatment |
| Q36322351 | Transcriptional regulation of myeloid-derived suppressor cells |
| Q37919352 | Tumor Induced Inactivation of Natural Killer Cell Cytotoxic Function; Implication in Growth, Expansion and Differentiation of Cancer Stem Cells |
| Q34525342 | Tumor induced hepatic myeloid derived suppressor cells can cause moderate liver damage |
| Q38123166 | Tumor-altered dendritic cell function: implications for anti-tumor immunity |
| Q35015663 | Tumor-associated macrophages in breast cancer. |
| Q37597961 | Tumor-mediated inhibition of dendritic cell differentiation is mediated by down regulation of protein kinase C beta II expression |
| Q37058110 | Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies |
| Q35831115 | Vascular endothelial growth factor impairs the functional ability of dendritic cells through Id pathways. |
| Q39091474 | Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation |
| Q33623988 | Weekday of Surgery Affects Postoperative Complications and Long-Term Survival of Chinese Gastric Cancer Patients after Curative Gastrectomy. |